CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Finite-Lived Intangible Asset, Expected Amortization, Year One
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) had Finite-Lived Intangible Asset, Expected Amortization, Year One of $70.05 million as of 2025-12-27, per its 10-K filed 2026-02-18.
Financial Statements › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths · last filed 2026-02-18
- 2025-12-27: Finite-Lived Intangible Asset, Expected Amortization, Year One $70.05M.
- 2024-12-28: Finite-Lived Intangible Asset, Expected Amortization, Year One $185.78M.
- 2023-12-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $129.15M.
- 2022-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $134.31M.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year One |
|---|---|
| 2025-12-27 | $70.05M 10-K · filed 2026-02-18 |
| 2024-12-28 | $185.78M 10-K · filed 2025-02-19 |
| 2023-12-30 | $129.15M 10-K · filed 2024-02-14 |
| 2022-12-31 | $134.31M 10-K · filed 2023-02-22 |
| 2021-12-25 | $143.20M 10-K · filed 2022-02-16 |
| 2020-12-26 | $104.27M 10-K · filed 2021-02-17 |
| 2019-12-28 | $97.02M 10-K · filed 2020-02-11 |
| 2018-12-29 | $77.17M 10-K · filed 2019-02-13 |
| 2017-12-30 | $38.26M 10-K · filed 2018-02-13 |
| 2016-12-31 | $42.52M 10-K · filed 2017-02-14 |
| 2015-12-26 | $26.84M 10-K · filed 2016-02-12 |
| 2014-12-27 | $21.12M 10-K · filed 2015-02-17 |
| 2013-12-28 | $16.40M 10-K · filed 2014-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |